- Home
- ARWR vs CFR Comparison
ARWR vs CFR Comparison
Compare ARWR & CFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ARWR | CFR |
|---|---|---|
| Founded | 2003 | 1868 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.6B | 8.1B |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | ARWR | CFR |
|---|---|---|
| Price | $67.81 | $143.63 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 14 |
| Target Price | $73.70 | ★ $137.64 |
| AVG Volume (30 Days) | ★ 2.6M | 428.3K |
| Earning Date | 02-05-2026 | 01-29-2026 |
| Dividend Yield | N/A | ★ 2.91% |
| EPS Growth | N/A | ★ 20.47 |
| EPS | N/A | ★ 9.72 |
| Revenue | $829,448,000.00 | ★ $2,141,575,000.00 |
| Revenue This Year | N/A | $14.17 |
| Revenue Next Year | N/A | $4.38 |
| P/E Ratio | ★ N/A | $14.13 |
| Revenue Growth | ★ 23258.15 | 9.02 |
| 52 Week Low | $9.57 | $100.31 |
| 52 Week High | $76.76 | $146.44 |
Technical Indicators
Market Signals| Indicator | ARWR | CFR |
|---|---|---|
| Relative Strength Index (RSI) | 57.08 | 74.69 |
| Support Level | $61.65 | $134.57 |
| Resistance Level | $68.24 | $139.98 |
| Average True Range (ATR) | 3.79 | 3.21 |
| MACD | -0.69 | 0.67 |
| Stochastic Oscillator | 45.29 | 98.33 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About CFR Cullen/Frost Bankers Inc.
Cullen/Frost is a regional US bank with around $53 billion in assets (as of September 2025), and it focuses exclusively on the Texas market. The bank has deep expertise in this market. It has implemented a relationship-based approach to banking that has garnered a strong market share in San Antonio. Cullen/Frost is also expanding into Houston, Dallas, and Austin market regions through branch openings. The bank's sweet spot is small to medium-size Texas-based commercial clients.